Actionnariat et activité des initiés pour Perspective Therapeutics, Inc. (CATX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.70 |
| Capitalisation | $308M |
| Bourse | AMEX |
| Pays | US |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $5.9M | $2.6M | $5.3M | $2.4M | $9.6M | $55.9M | $21.0M | $9.2M | $61.6M | $30.6M |
| Placements à Court Terme | $3.0M | $825000 | 0 | 0 | 0 | 0 | $22.8M | 0 | $165.3M | $114.1M |
| Créances | $726000 | $1.2M | $1.2M | $2.0M | $1.7M | $1.6M | $1.4M | $1.2M | $116000 | $1.0M |
| Stocks | $323000 | $516000 | $530000 | $645000 | $665000 | $1.4M | $1.4M | 0 | 0 | 0 |
| Actifs Courants | $10.3M | $5.5M | $7.3M | $5.5M | $12.3M | $59.3M | $53.2M | $16.8M | $231.2M | $148.4M |
| Immobilisations Corporelles | $1.1M | $1.3M | $1.6M | $2.7M | $2.7M | $2.5M | $371000 | $6.3M | $59.5M | $78.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24.1M | 0 | 0 |
| Actifs Incorporels | $230000 | $198000 | $162000 | $138000 | $130000 | $107000 | $25000 | $50.4M | $50.0M | $40.0M |
| Actifs Totaux | $12.3M | $7.5M | $9.4M | $8.7M | $15.5M | $64.4M | $58.1M | $97.9M | $341.1M | $267.0M |
| Dettes Fournisseurs | $630000 | $1.4M | $683000 | $654000 | $494000 | $966000 | $1.5M | $6.9M | $10.3M | $20.5M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $49000 | $52000 | $56000 |
| Passifs Courants | $1.1M | $1.8M | $1.1M | $1.6M | $1.3M | $2.3M | $3.1M | $15.7M | $18.2M | $28.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.7M | $1.6M | $1.6M |
| Passifs Totaux | $1.7M | $2.4M | $1.7M | $3.0M | $2.7M | $3.2M | $3.4M | $22.7M | $50.4M | $59.9M |
| Réserves | -$72.6M | -$79.3M | -$84.5M | -$87.9M | -$89.5M | -$98.6M | -$105.9M | -$152.4M | -$231.7M | -$334.8M |
| Capitaux Propres | $10.6M | $5.0M | $7.7M | $5.7M | $12.8M | $61.3M | $54.6M | $75.2M | $290.7M | $207.0M |
| Dette Totale | 0 | 0 | 0 | $1.0M | $897000 | $524000 | $524000 | $2.6M | $4.1M | $3.3M |
| Dette Nette | -$9.0M | -$3.4M | -$5.3M | -$1.4M | -$8.7M | -$55.4M | -$43.2M | -$6.7M | -$222.9M | -$141.5M |
| Fonds de Roulement | $9.2M | $3.6M | $6.2M | $3.9M | $11.0M | $57.1M | $50.1M | $1.2M | $212.9M | $119.7M |
Santé financière
| Dette / Capitaux propres | 0.01 |
| Ratio de liquidité | 6.61 |
Rentabilité
| Rentabilité des capitaux propres | -41.56% |
| Rentabilité du capital investi | -34.94% |
| Rentabilité des actifs | -29.70% |
| Marge brute | -419.40% |
| Marge opérationnelle | -34216.39% |
| Marge nette | -31812.57% |
Entreprises liées: AVR · ELMD · HSDT · IVVD · MXCT · NNOX · NYXH
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de CATX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions